Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptonemal complex central element protein 1 (SYCE1) is a structural protein integral to the central element of the synaptonemal complex, a meiosis-specific structure that physically links homologous chromosomes during prophase I of meiosis[1][2][4]. SYCE1 plays a crucial role in the initiation and elongation of synapsis, making it essential for homologous chromosome pairing and recombination[1][2]. The protein is composed predominantly of α-helical coiled-coil domains, forming an anti-parallel dimer that acts as a physical strut to stabilize the central region of the synaptonemal complex[1]. SYCE1 interacts with other synaptonemal complex proteins such as SYCP1 and SYCE3, and its function is indispensable for correct meiotic chromosome segregation[3]. Mutations in SYCE1 have been associated with specific human infertility disorders including premature ovarian failure and spermatogenic failure[2]. Currently, SYCE1 is not a therapeutic target for drugs but is an important biomarker for genetic diagnosis in reproductive medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptonemal complex central element protein 1 (SYCE1).